摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(S)-2-(1,4-dioxaspiro[4.5]-decan-2-yl)pent-4-enal | 1231913-19-1

中文名称
——
中文别名
——
英文名称
(S)-2-(1,4-dioxaspiro[4.5]-decan-2-yl)pent-4-enal
英文别名
2-((S)-1,4-dioxaspiro[4.5]decan-2-yl)pent-4-enal;2-[(3S)-1,4-dioxaspiro[4.5]decan-3-yl]pent-4-enal
(S)-2-(1,4-dioxaspiro[4.5]-decan-2-yl)pent-4-enal化学式
CAS
1231913-19-1
化学式
C13H20O3
mdl
——
分子量
224.3
InChiKey
UAGNLEOEMALMDG-PIJUOVFKSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.1
  • 重原子数:
    16
  • 可旋转键数:
    4
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.77
  • 拓扑面积:
    35.5
  • 氢给体数:
    0
  • 氢受体数:
    3

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    (S)-2-(1,4-dioxaspiro[4.5]-decan-2-yl)pent-4-enal 在 sodium tetrahydroborate 、 草酰氯二甲基亚砜 作用下, 以 甲醇二氯甲烷 为溶剂, 反应 2.75h, 生成 (S)-2-((S)-1,4-dioxaspiro[4.5]decan-2-yl)pent-4-enal
    参考文献:
    名称:
    以手性4-戊烯醇衍生物为结构单元的阿尔茨海默氏病治疗药(R)-(-)和(S)-(+)-金刚烷酸的立体发散方法
    摘要:
    从手性和非手性材料都已经实现了抗阿尔茨海默病药物(R)-(-)和(S)-(+)-金刚烷酸的有效立体发散性全合成。该策略的特征是采用脯氨酸催化的不对称α-氨基氧基化和[3,3]σ克莱森重排的可分离非对映体C-2手性4-戊烯醇中间体的有效方法是本合成的重点。
    DOI:
    10.1016/j.tet.2017.03.002
  • 作为产物:
    描述:
    (S)-2-(2-(allyloxy)-vinyl)-1,4-dioxospiro[4.5]-decane 以 5,5-dimethyl-1,3-cyclohexadiene 为溶剂, 以97%的产率得到(S)-2-(1,4-dioxaspiro[4.5]-decan-2-yl)pent-4-enal
    参考文献:
    名称:
    The efficient synthesis of (3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-ol and its isomers
    摘要:
    The stereoselective synthesis of all the possible stereoisomers of bis-tetrahydrofyran alcohol, a ligand used for obtaining HIV protease inhibitors including Darunavir 1 and Brecanavir 2 has been achieved. A key intermediate 4-pentenal 5 was obtained by employing a Wittig olefination-Claisen rearrangement protocol from D-glyceraldehyde derivative 3 as a source of chirality. The 4-pentenal was readily converted in the bis-THF alcohol moiety in three steps. (C) 2010 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.tetasy.2010.08.005
点击查看最新优质反应信息

文献信息

  • A stereodivergent approach to carbahexofuranoses: synthesis of carba-α-d-glucofuranose, carba-β-d-altrofuranose, carba-α-d-allofuranose, carba-β-d-idofuranose, carba-α-d-galactofuranose and carba-β-d-talofuranose
    作者:Mukund G. Kulkarni、Ajit S. Borhade、Yunnus B. Shaikh、Attrimuni P. Dhondge、Deekshaputra R. Birhade、Nagorao R. Dhatrak
    DOI:10.1016/j.tetlet.2011.08.006
    日期:2011.10
    A stereodivergent route, starting from d-glyceraldehyde derivative, employing Wittig olefination–Claisen rearrangement protocol is reported for the synthesis of six novel carbahexofuranoses—carba-α-d-glucofuranose, carba-β-d-altrofuranose, carba-α-d-allofuranose, carba-β-d-idofuranose, carba-α-d-galactofuranose and carba-β-d-talofuranose in enantiomerically pure form.
    据报道,从d-甘油醛衍生物开始,采用Wittig烯烃化-Claisen重排方案的立体发散途径可合成六种新的碳呋喃呋喃糖酶,即carba-α-d-葡萄糖呋喃糖,carba-β-d-铝呋喃糖,carba-α-d-d-。对映体纯净形式的异呋喃糖,氨基甲酸酯-β-d-呋喃二糖,氨基甲酸酯-α-d-半乳糖呋喃糖和氨基甲酸酯-β-d-塔拉呋喃糖。
  • Stereodivergent approach to Alzheimer's therapeutic agent ( R )-(−) and ( S )-(+)-arundic acid employing chiral 4-pentenol derivatives as building blocks
    作者:Viraj A. Bhosale、Suresh B. Waghmode
    DOI:10.1016/j.tet.2017.03.002
    日期:2017.4
    An efficient stereodivergent total synthesis of anti-Alzheimer agent (R)-() and (S)-(+)-arundic acid has been achieved from both chiral and nonchiral materials. This strategy features an efficient approach to separable diastereomeric C-2 chiral 4-pentenol intermediates employing proline catalysed asymmetric α-aminooxylation and [3,3] sigmatropic Claisen rearrangement are the highlights of present
    从手性和非手性材料都已经实现了抗阿尔茨海默病药物(R)-(-)和(S)-(+)-金刚烷酸的有效立体发散性全合成。该策略的特征是采用脯氨酸催化的不对称α-氨基氧基化和[3,3]σ克莱森重排的可分离非对映体C-2手性4-戊烯醇中间体的有效方法是本合成的重点。
  • The efficient synthesis of (3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-ol and its isomers
    作者:Mukund G. Kulkarni、Yunnus B. Shaikh、Ajit S. Borhade、Attrimuni P. Dhondge、Sanjay W. Chavhan、Mayur P. Desai、Deekshaputra R. Birhade、Nagorao R. Dhatrak、Ramesh Gannimani
    DOI:10.1016/j.tetasy.2010.08.005
    日期:2010.10
    The stereoselective synthesis of all the possible stereoisomers of bis-tetrahydrofyran alcohol, a ligand used for obtaining HIV protease inhibitors including Darunavir 1 and Brecanavir 2 has been achieved. A key intermediate 4-pentenal 5 was obtained by employing a Wittig olefination-Claisen rearrangement protocol from D-glyceraldehyde derivative 3 as a source of chirality. The 4-pentenal was readily converted in the bis-THF alcohol moiety in three steps. (C) 2010 Elsevier Ltd. All rights reserved.
查看更多